The store will not work correctly when cookies are disabled.
3-(1-naphthoxy)propoxy-2,6-difluorobenzamide
ID: ALA4104199
PubChem CID: 137658012
Max Phase: Preclinical
Molecular Formula: C20H17F2NO3
Molecular Weight: 357.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1c(F)ccc(OCCCOc2cccc3ccccc23)c1F
Standard InChI: InChI=1S/C20H17F2NO3/c21-15-9-10-17(19(22)18(15)20(23)24)26-12-4-11-25-16-8-3-6-13-5-1-2-7-14(13)16/h1-3,5-10H,4,11-12H2,(H2,23,24)
Standard InChI Key: XEKHAIOLZOSULY-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
28.6333 -21.6060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6322 -22.4255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3402 -22.8345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0499 -22.4251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3384 -21.1971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0434 -21.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7462 -21.1972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7454 -20.3834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0357 -19.9783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3358 -20.3876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7591 -22.8310 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.4653 -22.4197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1745 -22.8256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8807 -22.4143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5899 -22.8202 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.2961 -22.4089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0036 -22.8156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7092 -22.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7066 -21.5870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9923 -21.1812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2896 -21.5942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5787 -21.1911 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
36.4122 -21.1747 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.9864 -20.3641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6910 -19.9503 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2757 -19.9607 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 1 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 5 2 0
4 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
21 22 1 0
19 23 1 0
20 24 1 0
24 25 1 0
24 26 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 357.36 | Molecular Weight (Monoisotopic): 357.1176 | AlogP: 4.06 | #Rotatable Bonds: 7 |
Polar Surface Area: 61.55 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.97 | CX Basic pKa: ┄ | CX LogP: 3.65 | CX LogD: 3.65 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.65 | Np Likeness Score: -0.91 |
References
1. Hu Z, Zhang S, Zhou W, Ma X, Xiang G.. (2017) Synthesis and antibacterial activity of 3-benzylamide derivatives as FtsZ inhibitors., 27 (8): [PMID:28285910] [10.1016/j.bmcl.2017.02.032] |